Endothelin A-receptor antagonist administration immediately after experimental myocardial infarction with reperfusion does not affect scar healing in dogs [PDF]
, 2002 Cristina Basso
openalex +1 more source
Endothelin and other mediators in the pathophysiology of portal hypertension [PDF]
, 1998 Bilzer, Manfred +2 more
core +1 more source
SorCS2 Is Important for Astrocytic Function in Neurovascular Signaling
Acta Physiologica, Volume 241, Issue 6, June 2025.ABSTRACT Introduction The receptor SorCS2 is involved in the trafficking of membrane receptors and transporters. It has been implicated in brain disorders and has previously been reported to be indispensable for ionotropic glutamatergic neurotransmission in the hippocampus.
Christian Staehr +14 more
wiley +1 more source
Hypotension associated with systemic aggregated anaphylaxis is not attenuated by a selective endothelin-A receptor antagonist, BQ 610, in rabbits in vivo [PDF]
, 2003 Takayuki Kawakami +7 more
openalex +1 more source
Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience. [PDF]
Ther Adv Respir Dis, 2019 Belge C, Delcroix M.
europepmc +1 more source
Engineered pulmonary artery tissues for measuring contractility, drug testing and disease modelling
British Journal of Pharmacology, Volume 182, Issue 12, Page 2585-2602, June 2025.Abstract Background and Purpose Vasoreactivity of pulmonary arteries regulates blood flow through the lungs. Excessive constriction of these vessels contributes to pulmonary arterial hypertension (PAH), a progressive and incurable condition, resulting in right heart failure.
Adam L. Fellows +8 more
wiley +1 more source
Low dose tezosentan, an intravenous dual endothelin receptor antagonist, decreases type B-natruretic peptide levels in patients with acute decompensated heart failure [PDF]
, 2003 Guillermo Torre‐Amione +13 more
openalex +1 more source